Is Ucommune International Ltd (UK) a Buy, Sell, or Hold?
NASDAQ : UK
Ucommune International Ltd
$2.02 USD
-$0.05 (-2.42%)
- Volume
- 11.34K
- Average Volume
- 380.61K
- Market Capitalization
- $404.1K
- P/E Ratio
- -0.10
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $15.50
- Year Low
- $1.62
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.07
| Source | Headline |
|---|---|
|
IGI Expands Global Footprint as it Secures License to Operate in India's Gujarat International Finance Tec-City (GIFT City)
International General Insurance Holdings Ltd. (âIGIâ or the âCompanyâ) (NASDAQ: IGIC) today announced that it has secured registration approval from th gurufocus.com - 2026-06-08 10:00:00 |
|
Hirect Advances Heavy Haul Capability with Successful Loaded Run of 6,000 HP Locomotive Propulsion System
Hirect, a premier global manufacturer of heavy-duty electrical and power electronic components for rolling stock, today announced the successful integration an gurufocus.com - 2026-06-01 05:00:00 |
|
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi gurufocus.com - 2026-05-29 07:00:00 |
|
Phase 3 ASSURE Interim Data: Majority of People in the Study with ALP 1--1.67×ULN Achieved High and Sustained Composite ALP Normalization at 24 Months with Gilead's Livdelzi (Seladelpar)
Gilead Sciences, Inc. (Nasdaq: GILD) today shared new results from a post hoc analysis showing that Livdelzi (seladelpar) was associated with high and sustai gurufocus.com - 2026-05-27 03:00:00 |
|
Harel Insurance Investments and Financial Services reports first quarter 2026 results with strong momentum continues
Harel Insurance Investments and Financial Services reports first quarter 2026 results with strong momentum continues PR Newswir gurufocus.com - 2026-05-27 01:00:00 |
|
Hansa Biopharma enters into €115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA
Hansa Biopharma enters into â¬115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA PR New gurufocus.com - 2026-05-19 03:00:00 |
|
Bank Leumi opens 2026 with the strongest results in the system: Net income of approx. NIS 2.3 billion ($742 million) and dividend distribution of NIS 1.3 billion ($411 million)
Bank Leumi opens 2026 with the strongest results in the system: Net income of approx. NIS 2.3 billion ($742 million) and dividend distribution gurufocus.com - 2026-05-19 02:00:00 |
|
New Fortress Energy Inc. Announces Court Approval to Convene Plan Meetings
New Fortress Energy Inc. (NASDAQ: NFE) (âNFEâ or the âCompanyâ) is pleased to announce that it has achieved the next step in the implementation of a co gurufocus.com - 2026-05-18 10:00:00 |
